Heath Lukatch's most recent trade in Vaxcyte Inc was a trade of 15,372 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxcyte Inc | Heath Lukatch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 15,372 | 15,372 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Heath Lukatch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 3,041 | 17,216 | - | 0 | Common Stock | |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2025 | 6,000 | 0 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 08 Apr 2025 | 6,000 | 13,175 | - | 16 | 96,000 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2025 | 1,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.49 per share. | 08 Apr 2025 | 1,000 | 14,175 | - | 21.5 | 21,490 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,250 | 7,250 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Heath Lukatch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 1,550 | 7,175 | - | 0 | Common Stock | |
| Vaxcyte Inc | Lukatch Heath | Director | Sale of securities on an exchange or to another person at price $ 71.50 per share. | 31 Jan 2024 | 5,000 | 5,625 | - | 71.5 | 357,500 | Common Stock |
| Vaxcyte Inc | Lukatch Heath | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 5,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Lukatch Heath | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 31 Jan 2024 | 5,000 | 10,625 | - | 16 | 80,000 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 29 Jan 2024 | 4,000 | 9,625 | - | 16 | 64,000 | Common Stock |
| Vaxcyte Inc | Lukatch Heath | Director | Sale of securities on an exchange or to another person at price $ 67.50 per share. | 29 Jan 2024 | 4,000 | 5,625 | - | 67.5 | 270,000 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 4,000 | 11,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Lukatch Heath | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 02 Jan 2024 | 13,000 | 18,625 | - | 16 | 208,000 | Common Stock |
| Vaxcyte Inc | Lukatch Heath | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 13,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Heath Lukatch | Director | Sale of securities on an exchange or to another person at price $ 63.55 per share. | 02 Jan 2024 | 7,444 | 10,080 | - | 63.6 | 473,081 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Sale of securities on an exchange or to another person at price $ 64.28 per share. | 02 Jan 2024 | 4,164 | 5,916 | - | 64.3 | 267,662 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Sale of securities on an exchange or to another person at price $ 62.85 per share. | 02 Jan 2024 | 1,101 | 17,524 | - | 62.9 | 69,201 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Sale of securities on an exchange or to another person at price $ 65.19 per share. | 02 Jan 2024 | 291 | 5,625 | - | 65.2 | 18,971 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Heath Lukatch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 2,500 | 5,625 | - | 0 | Common Stock | |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 10 Jan 2023 | 315 | 3,440 | - | 16 | 5,040 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2023 | 315 | 28,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Heath Lukatch | Director | Sale of securities on an exchange or to another person at price $ 46.04 per share. | 10 Jan 2023 | 233 | 3,207 | - | 46.0 | 10,728 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Sale of securities on an exchange or to another person at price $ 46.33 per share. | 10 Jan 2023 | 82 | 3,125 | - | 46.3 | 3,799 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 335 | 28,315 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 12 Dec 2022 | 335 | 3,460 | - | 16 | 5,360 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Sale of securities on an exchange or to another person at price $ 44.01 per share. | 12 Dec 2022 | 319 | 3,125 | - | 44.0 | 14,039 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Sale of securities on an exchange or to another person at price $ 42.38 per share. | 12 Dec 2022 | 16 | 3,444 | - | 42.4 | 678 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2022 | 4,335 | 28,650 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 10 Nov 2022 | 4,335 | 7,460 | - | 16 | 69,360 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Sale of securities on an exchange or to another person at price $ 46.25 per share. | 10 Nov 2022 | 4,000 | 3,125 | - | 46.3 | 185,000 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Sale of securities on an exchange or to another person at price $ 44.74 per share. | 10 Nov 2022 | 335 | 7,125 | - | 44.7 | 14,989 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Oct 2022 | 4,000 | 32,985 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Heath Lukatch | Director | Sale of securities on an exchange or to another person at price $ 38.25 per share. | 24 Oct 2022 | 4,000 | 3,125 | - | 38.3 | 153,000 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 24 Oct 2022 | 4,000 | 7,125 | - | 16 | 64,000 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Sale of securities on an exchange or to another person at price $ 35.11 per share. | 24 Oct 2022 | 3,015 | 3,125 | - | 35.1 | 105,857 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 24 Oct 2022 | 3,015 | 6,140 | - | 16 | 48,240 | Common Stock |
| Vaxcyte Inc | Heath Lukatch | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Oct 2022 | 3,015 | 36,985 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Heath Lukatch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 18,750 | 18,750 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Heath Lukatch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,125 | 3,125 | - | 0 | Common Stock | |
| Vaxcyte Inc | Heath Lukatch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Inogen Inc | Heath Lukatch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2021 | 2,754 | 12,775 (0%) | 0% | 0 | Common Stock |